AI assistant
Sending…
GERON CORP — Director's Dealing 2013
May 7, 2013
32370_dirs_2013-05-07_794429b4-7ea9-47f9-b8d2-e7d3322bb98f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2013-05-03
Reporting Person: Kelsey Stephen Michael (EVP, R&D, Chief Med Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-03 | Common Stock | D | 386875 | — | Disposed | 62272 | Direct |
Footnotes
F1: Forfeiture of unvested restricted stock awards in connection with separation of employment from the company.
More from GERON CORP
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
May 8
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26